These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 3471327)

  • 1. A National Institutes of Health Workshop Report. Cellular and molecular mechanisms for suppression and reversion of tumorigenicity. A Chemical Pathology Study Section workshop.
    Barrett JC
    Cancer Res; 1987 May; 47(9):2514-20. PubMed ID: 3471327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
    Klinger HP; Shows TB
    J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polypeptide growth factors in animal embryogenesis].
    Stoĭka RS; Kusen' SI
    Ontogenez; 1988; 19(3):229-39. PubMed ID: 3050668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Expression of malignancy traits in the interspecific somatic hybrids of tumor and normal cells].
    Kakpakova ES
    Genetika; 1983 Nov; 19(11):1845-50. PubMed ID: 6317520
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
    Martin GM; Ogburn CE; Au K; Disteche CM
    J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of carcinogenesis: the role of oncogenes, transcriptional enhancers and growth factors.
    Spandidos DA
    Anticancer Res; 1985; 5(5):485-98. PubMed ID: 3904595
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of tumorigenicity in somatic cell hybrids does not involve quantitative changes in transcription of cellular Ha-ras, Ki-ras, myc, and fos oncogenes.
    Schäfer R; Geisse S; Willecke K
    J Cell Biochem; 1987 May; 34(1):31-8. PubMed ID: 3584261
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Retrovirus, oncogenes and transformation].
    Varnier OE; Muratore O; Romanzi CA
    Quad Sclavo Diagn; 1984 Dec; 20(4):418-34. PubMed ID: 6537551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Tumor suppressor genes. New perspectives for clinical investigations in cancer].
    Paván J; Gualandi F; Rimessi P; Corallini A; Barbanti-Brodano G
    Medicina (B Aires); 1994; 54(2):163-8. PubMed ID: 7997135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncogene activation and tumor suppressor gene inactivation during multistage mouse skin carcinogenesis.
    Bowden GT; Schneider B; Domann R; Kulesz-Martin M
    Cancer Res; 1994 Apr; 54(7 Suppl):1882s-1885s. PubMed ID: 8137304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemical carcinogenesis and the oncogenes--a Chemical Pathology Study Section Workshop.
    Bowden GT
    Cancer Res; 1985 Feb; 45(2):914-8. PubMed ID: 3967251
    [No Abstract]   [Full Text] [Related]  

  • 12. The Ha-ras-induced transformed phenotype of rat-1 cells can be suppressed in hybrids with rat embryonic fibroblasts.
    Willecke K; Griegel S; Martin W; Traub O; Schäfer R
    J Cell Biochem; 1987 May; 34(1):23-30. PubMed ID: 3495543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reexpression of neu-encoded oncoprotein counteracts the tumor-suppressing but not the metastasis-suppressing function of E1A.
    Yu D; Shi D; Scanlon M; Hung MC
    Cancer Res; 1993 Dec; 53(23):5784-90. PubMed ID: 7902209
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumorigenesis by transected cells in nude mice: a new method for detecting cellular transforming genes.
    Blair DG; Cooper CS; Oskarsson MK; Eader LA; Vande Woude GF
    Prog Clin Biol Res; 1983; 119():79-90. PubMed ID: 6346333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A functional genomics approach for the identification of putative tumor suppressor genes: Dickkopf-1 as suppressor of HeLa cell transformation.
    Mikheev AM; Mikheeva SA; Liu B; Cohen P; Zarbl H
    Carcinogenesis; 2004 Jan; 25(1):47-59. PubMed ID: 14555616
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Experimental evidence for a unifying concept of the molecular mechanisms of the cellular aging and the cellular neoplastic transformation.
    Kontermann K; Bayreuther K
    Aktuelle Gerontol; 1978 Aug; 8(8):411-8. PubMed ID: 29505
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Workshop report from the Division of Research Grants, National Institutes of Health. Molecular genetic approaches to the analysis of malignant transformation--a pathology B study section workshop.
    Furmanski P; Chisari F; Pellicer A; Fausto N; Padarathsingh M
    Cancer Res; 1990 Jun; 50(12):3805-6. PubMed ID: 1692768
    [No Abstract]   [Full Text] [Related]  

  • 18. Loss of differentiation control in transformed 3T3 T proadipocytes.
    Sparks RL; Allen BJ; Zygmunt AI; Strauss EE
    Cancer Res; 1993 Apr; 53(8):1770-6. PubMed ID: 8467495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Morphological transformation, tumorigenicity and src-specific cytotoxic T-lymphocyte-mediated tumor immunity induced by murine 3T3 cells expressing src oncogenes encoding novel non-myristylated N-terminal domains.
    Gelman IH; Khan S; Hanafusa H
    Oncogene; 1993 Nov; 8(11):2995-3004. PubMed ID: 7692370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Malignant cell transformation and oncogenes].
    Kiselev FL
    Genetika; 1985 Jun; 21(6):885-95. PubMed ID: 3928437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.